Mesa Laboratories Statistics
Total Valuation
MLAB has a market cap or net worth of $529.72 million. The enterprise value is $694.50 million.
Important Dates
The next estimated earnings date is Monday, August 4, 2025, before market open.
Earnings Date | Aug 4, 2025 |
Ex-Dividend Date | May 30, 2025 |
Share Statistics
MLAB has 5.46 million shares outstanding. The number of shares has increased by 0.65% in one year.
Current Share Class | 5.46M |
Shares Outstanding | 5.46M |
Shares Change (YoY) | +0.65% |
Shares Change (QoQ) | +0.18% |
Owned by Insiders (%) | 2.55% |
Owned by Institutions (%) | 95.60% |
Float | 5.31M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 12.71 |
PS Ratio | 2.18 |
Forward PS | 2.07 |
PB Ratio | 3.31 |
P/TBV Ratio | n/a |
P/FCF Ratio | 12.45 |
P/OCF Ratio | 11.32 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 16.50, with an EV/FCF ratio of 16.32.
EV / Earnings | n/a |
EV / Sales | 2.88 |
EV / EBITDA | 16.50 |
EV / EBIT | 39.53 |
EV / FCF | 16.32 |
Financial Position
The company has a current ratio of 0.63, with a Debt / Equity ratio of 1.21.
Current Ratio | 0.63 |
Quick Ratio | 0.43 |
Debt / Equity | 1.21 |
Debt / EBITDA | 4.04 |
Debt / FCF | 4.55 |
Interest Coverage | 1.48 |
Financial Efficiency
Return on equity (ROE) is -1.29% and return on invested capital (ROIC) is 3.01%.
Return on Equity (ROE) | -1.29% |
Return on Assets (ROA) | 2.50% |
Return on Invested Capital (ROIC) | 3.01% |
Return on Capital Employed (ROCE) | 6.52% |
Revenue Per Employee | $330,107 |
Profits Per Employee | -$2,704 |
Employee Count | 730 |
Asset Turnover | 0.55 |
Inventory Turnover | 3.06 |
Taxes
In the past 12 months, MLAB has paid $7.94 million in taxes.
Income Tax | 7.94M |
Effective Tax Rate | 133.12% |
Stock Price Statistics
The stock price has increased by +2.31% in the last 52 weeks. The beta is 0.89, so MLAB's price volatility has been lower than the market average.
Beta (5Y) | 0.89 |
52-Week Price Change | +2.31% |
50-Day Moving Average | 112.10 |
200-Day Moving Average | 124.53 |
Relative Strength Index (RSI) | 34.42 |
Average Volume (20 Days) | 100,908 |
Short Selling Information
The latest short interest is 183,161, so 3.36% of the outstanding shares have been sold short.
Short Interest | 183,161 |
Short Previous Month | 185,209 |
Short % of Shares Out | 3.36% |
Short % of Float | 3.45% |
Short Ratio (days to cover) | 4.64 |
Income Statement
In the last 12 months, MLAB had revenue of $240.98 million and -$1.97 million in losses. Loss per share was -$0.36.
Revenue | 240.98M |
Gross Profit | 152.10M |
Operating Income | 17.57M |
Pretax Income | -270.81M |
Net Income | -1.97M |
EBITDA | 42.10M |
EBIT | 17.57M |
Loss Per Share | -$0.36 |
Full Income Statement Balance Sheet
The company has $29.07 million in cash and $193.85 million in debt, giving a net cash position of -$164.78 million or -$30.20 per share.
Cash & Cash Equivalents | 29.07M |
Total Debt | 193.85M |
Net Cash | -164.78M |
Net Cash Per Share | -$30.20 |
Equity (Book Value) | 159.83M |
Book Value Per Share | 29.30 |
Working Capital | -61.28M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $46.81 million and capital expenditures -$4.25 million, giving a free cash flow of $42.56 million.
Operating Cash Flow | 46.81M |
Capital Expenditures | -4.25M |
Free Cash Flow | 42.56M |
FCF Per Share | $7.80 |
Full Cash Flow Statement Margins
Gross margin is 63.12%, with operating and profit margins of 7.29% and -0.82%.
Gross Margin | 63.12% |
Operating Margin | 7.29% |
Pretax Margin | 2.47% |
Profit Margin | -0.82% |
EBITDA Margin | 17.47% |
EBIT Margin | 7.29% |
FCF Margin | 17.66% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 0.66%.
Dividend Per Share | $0.64 |
Dividend Yield | 0.66% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.65% |
Shareholder Yield | 0.01% |
Earnings Yield | -0.37% |
FCF Yield | 8.03% |
Dividend Details Analyst Forecast
The average price target for MLAB is $130.00, which is 33.17% higher than the current price. The consensus rating is "Hold".
Price Target | $130.00 |
Price Target Difference | 33.17% |
Analyst Consensus | Hold |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
MLAB has an Altman Z-Score of 1.34 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.34 |
Piotroski F-Score | 6 |